Am J Trop Med Hyg:强力霉素可预防疟疾的同时降低国际旅行者流行性感冒病的风险

2020-02-19 不详 网络

旅行者通常同时面临类流感(ILI)和疟疾的风险。强力霉素对引起ILI的病原体具有活性,可用于预防疟疾。我们评估了ILI的危险因素,以及预防疟疾的选择是否与ILI有关。 TravMil是一项前瞻性观察研究,招募到军事旅行诊所就诊的受试者。流感样疾病的定义是主观发烧伴有喉咙痛或咳嗽。分析旅行的特征和预防疟疾的用途,以确定与ILI发生的关系。使用具有强大误差方差的Poisson回归模型用于估计ILI的相

旅行者通常同时面临类流感(ILI)和疟疾的风险。强力霉素对引起ILI的病原体具有活性,可用于预防疟疾。我们评估了ILI的危险因素,以及预防疟疾的选择是否与ILI有关。

TravMil是一项前瞻性观察研究,招募到军事旅行诊所就诊的受试者。流感样疾病的定义是主观发烧伴有喉咙痛或咳嗽。分析旅行的特征和预防疟疾的用途,以确定与ILI发生的关系。使用具有强大误差方差的Poisson回归模型用于估计ILI的相对风险(RR)。

总共登记了3,227次旅行:男性62.1%,中位年龄39岁(四分位间距[IQR] 27,59),平均旅行时间19天(IQR 12,49);32%的人去了非洲,40%的人去了亚洲,27%的人去了加勒比和拉丁美洲。出行最常见的原因是军事旅行(46%)和度假(40%)。其中,有20%服用了强力霉素,有50%采取了其他预防措施,有30%没有服用。

结果,8.7%的人发展了ILI ILI的RR降低与强力霉素(RR 0.65 [0.43-0.99],P = 0.046)和军事旅行有关(RR 0.30 [0.21-0.43],P <0.01)。女性患ILI的风险增加(RR 1.57 [1.24-1.98],P <0.01),前往亚洲旅行(RR 1.37 [1.08-1.75],P = 0.01)和乘船旅行(RR 2.21 [1.73-2.83],P <0.01)。

综上所述,该研究结果表明,使用强力霉素预防疟疾可降低ILI风险。可能的原因包括抗炎或抗菌作用或其他无法衡量的因素。由于很少有减少旅行者ILI的策略,这些发现有待进一步研究。

原始出处:

Lago K, Telu K, et al., Impact of Doxycycline as Malaria Prophylaxis on Risk of Influenza-Like Illness among International Travelers. Am J Trop Med Hyg. 2020 Feb 10. doi: 10.4269/ajtmh.19-0648. 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1703772, encodeId=e7b71e03772fd, content=<a href='/topic/show?id=354c50120d9' target=_blank style='color:#2F92EE;'>#强力霉素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50120, encryptionId=354c50120d9, topicName=强力霉素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e89530580294, createdName=楚秀娟, createdTime=Wed Nov 04 02:22:00 CST 2020, time=2020-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927326, encodeId=6050192e326d1, content=<a href='/topic/show?id=b95b653e389' target=_blank style='color:#2F92EE;'>#流行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65373, encryptionId=b95b653e389, topicName=流行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Fri Aug 28 11:22:00 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374230, encodeId=7cd813e42306f, content=<a href='/topic/show?id=583e653e556' target=_blank style='color:#2F92EE;'>#流行性感冒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65375, encryptionId=583e653e556, topicName=流行性感冒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Fri Feb 21 10:22:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610270, encodeId=907016102e026, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Feb 21 10:22:00 CST 2020, time=2020-02-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1703772, encodeId=e7b71e03772fd, content=<a href='/topic/show?id=354c50120d9' target=_blank style='color:#2F92EE;'>#强力霉素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50120, encryptionId=354c50120d9, topicName=强力霉素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e89530580294, createdName=楚秀娟, createdTime=Wed Nov 04 02:22:00 CST 2020, time=2020-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927326, encodeId=6050192e326d1, content=<a href='/topic/show?id=b95b653e389' target=_blank style='color:#2F92EE;'>#流行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65373, encryptionId=b95b653e389, topicName=流行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Fri Aug 28 11:22:00 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374230, encodeId=7cd813e42306f, content=<a href='/topic/show?id=583e653e556' target=_blank style='color:#2F92EE;'>#流行性感冒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65375, encryptionId=583e653e556, topicName=流行性感冒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Fri Feb 21 10:22:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610270, encodeId=907016102e026, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Feb 21 10:22:00 CST 2020, time=2020-02-21, status=1, ipAttribution=)]
    2020-08-28 tulenzi
  3. [GetPortalCommentsPageByObjectIdResponse(id=1703772, encodeId=e7b71e03772fd, content=<a href='/topic/show?id=354c50120d9' target=_blank style='color:#2F92EE;'>#强力霉素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50120, encryptionId=354c50120d9, topicName=强力霉素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e89530580294, createdName=楚秀娟, createdTime=Wed Nov 04 02:22:00 CST 2020, time=2020-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927326, encodeId=6050192e326d1, content=<a href='/topic/show?id=b95b653e389' target=_blank style='color:#2F92EE;'>#流行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65373, encryptionId=b95b653e389, topicName=流行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Fri Aug 28 11:22:00 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374230, encodeId=7cd813e42306f, content=<a href='/topic/show?id=583e653e556' target=_blank style='color:#2F92EE;'>#流行性感冒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65375, encryptionId=583e653e556, topicName=流行性感冒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Fri Feb 21 10:22:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610270, encodeId=907016102e026, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Feb 21 10:22:00 CST 2020, time=2020-02-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1703772, encodeId=e7b71e03772fd, content=<a href='/topic/show?id=354c50120d9' target=_blank style='color:#2F92EE;'>#强力霉素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50120, encryptionId=354c50120d9, topicName=强力霉素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e89530580294, createdName=楚秀娟, createdTime=Wed Nov 04 02:22:00 CST 2020, time=2020-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927326, encodeId=6050192e326d1, content=<a href='/topic/show?id=b95b653e389' target=_blank style='color:#2F92EE;'>#流行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65373, encryptionId=b95b653e389, topicName=流行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Fri Aug 28 11:22:00 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374230, encodeId=7cd813e42306f, content=<a href='/topic/show?id=583e653e556' target=_blank style='color:#2F92EE;'>#流行性感冒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65375, encryptionId=583e653e556, topicName=流行性感冒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Fri Feb 21 10:22:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610270, encodeId=907016102e026, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Feb 21 10:22:00 CST 2020, time=2020-02-21, status=1, ipAttribution=)]